share_log
Breakings ·  Nov 5 15:00
Nxera Pharma and Antiverse Enter Collaboration to Design Novel Gpcr-Targeted Antibody Therapeutics Using Generative AI
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment